首页 资讯 财经 生活 关注 科技 房产 企业 时尚 图库

健康

旗下栏目: 汽车 娱乐 教育 健康

全以祖-国泰综合医院内科部 风湿免疫科主治医师

来源:中国视窗网 作者:小渠 人气: 发布时间:2020-06-18
摘要:姓名: 全以祖(I-TsuChyuan) 工作单位: 国泰综合医院内科部 风湿免疫科 现职 : 国泰综合医院内科部 风湿免疫科专任主治医师 国泰综合医院医学研究部 副主任 国泰

 

姓名:

全以祖(I-TsuChyuan)

工作单位:

国泰综合医院内科部 风湿免疫科

 

现职:

 

国泰综合医院内科部 风湿免疫科专任主治医师

国泰综合医院医学研究部 副主任

国泰综合医院临床医学研究中心 主持人

辅仁大学医学系专任助理教授

台湾大学附设医院内科部 风湿免疫科兼任主治医师

 

学历:

 

2014-2018

国立台湾大学临床医学研究所博士

1998-2005

国立台湾大学医学系学士

 

经历:

 

2012-2014

台湾大学附设医院新竹分院内科部 风湿免疫科主治医师

2010-2012

台湾大学附设医院内科部 风湿免疫科总医师暨研究员

2007-2010

台湾大学附设医院内科部 住院医师

 

特殊荣誉与得奖纪录:

 

2019

2018

2019亚洲克隆氏症及大肠炎学会研究奖助金

财团法人沈水德翁文教基金会优秀论文奖

2018

第34届生物医学联合学术年会最佳口头报告奖

2016

中华民国免疫学会最佳口头报告奖

2015

财团法人沈水德翁文教基金会优秀论文奖

 

主持人计划

 

2019-2022

2019-2020

2016-2019

2016-2017

科技部专题研究计划

台大医院教研国泰综合医院合作研究计划

科技部专题研究计划

台大医院教研国泰综合医院合作研究计划

2015-2016

科技部专题研究计划

2015-2016

台大医院教研国泰综合医院合作研究计划

 

著作:

 

  1. Chyuan IT,Tsai HF, Wu CS, Hsu PN. TRAIL suppresses gut inflammation andinhibits colitogenic T cell activation in experimental colitis viaan apoptosis-independent pathway. MucosalImmunol. 2019;12(4):980-989(IF: 7.352)

 

  1. Liao HJ, Tsai HF, Wu CS, ChyuanIT, Hsu PN. TRAIL inhibits RANKsignaling and suppresses osteoclast activation via inhibiting lipidraft assembly and TRAF6 recruitment. CellDeath Dis. 2019;10(2):77. (IF:5.638)

 

  1. Chyuan IT,Chen JY. Role of Interleukin-(IL-)17 in the pathogenesis andtargeted therapies in spondyloarthropathies. MediatorsInflamm. 2018;2018:2403935.(IF: 3.549)

 

  1. Chyuan IT,Tsai HF, Wu CS, Sung CC, Hsu PN. TRAIL-mediated suppression of Tcell receptor signaling inhibits T cell activation and inflammationin experimental autoimmune encephalomyelitis. FrontImmunol. 2018;9:15. (IF: 6.429)

 

  1. Chyuan IT,Hsu PN. Tumor necrosis factor: The key to hepatitis B viralclearance. Cell Mol Immunol.2018;15(8):731-733. (IF: 7.551)

 

  1. Yang NY, Wang CY, ChyuanIT, Wu KJ, Tu YK, Chang CW, HsuPN, Kuo MY, Chen YW. Significant association of rheumatoidarthritis-related inflammatory markers with non-surgical periodontaltherapy. J Formos Med Assoc.2018;117(11):1003-1010. (IF: 2.452)

 

  1. Chyuan IT,Tsai HF, Liao HJ, Wu CS, Hsu PN. An apoptosis-independent role ofTRAIL in suppressing joint inflammation and inhibiting T cellactivation in inflammatory arthritis. CellMol Immunol.2018;15(9):846-857. (IF: 7.551)

 

  1. Tsai HF, Wu CS, Chen YL, Liao HJ, ChyuanIT, Hsu PN. Galectin-3suppresses mucosal inflammation and reduces disease severity inexperimental colitis. J Mol Med(Berl). 2016;94(5):545-56 (IF:4.938)

 

  1. Wang CY, ChyuanIT, Wang YL, Kuo MY, Chang CW,Wu KJ, Hsu PN, Nagasawa T, Wara-Aswapati N, Chen YW. β2-glycoproteinI-dependent anti-CL antibodies associated with periodonitis in SLEpatients. J Periodontol.2015;86(8):995-1004. (IF: 3.392)

 

  1. Chyuan IT,Tsai HF, Tzeng HT, Sung CC, Wu CS, Chen PJ, Hsu PN. Tumor necrosisfactor-alpha blockage therapy impairs hepatitis B viral clearanceand enhances T cell exhaustion in a mouse model. CellMol Immunol. 2015;12(3):317-25.(IF: 7.551)

 

  1. Liao HJ*, ChyuanIT*, Wu CS, Lin SW, Chen KH,Tsai HF, Hsu PN. Increased neutrophil infiltration, IL-1 productionand a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice.Rheumatology.2015;54(7):1317-26 (IF: 5.245)  *: co-first author

 

  1. Chyuan IT,Tsai TH, Chang TH, Wu CS. Ustekinumab treatment in a patient withpsoriasis and systemic lupus erythematosus. Lupus.2015;24(6):650-1. (IF: 2.969)

 

  1. Tzeng HT, Tsai HF, ChyuanIT, Liao HJ, Chen CJ, Chen PJ,Hsu PN. Tumor necrosis factor-alpha induced by hepatitis B viruscore mediating the immune response for hepatitis B viral clearancein mice model. PLoS One.2014;9(7):e103008. (IF: 2.766)

 

  1. Wu CS, Hu CY, Tsai HF, ChyuanIT, Chan CJ, Chang SK, Hsu PN.Elevated serum level of growth arrest-specific protein 6 (Gas6) insystemic lupus erythematosus patients is associated with nephritisand cutaneous vasculitis. RheumatolInt. 2014;34(5):625-9. (IF:1.952)

 

会议与座谈会:

 

  1. Chyuan IT,Tsai HF, Hsu PN. An apoptosis-independent role of TRAIL mediatessuppression of T cell activation and autoimmune inflammation inexperimental autoimmune encephalomyelitis [Poster]. The Federationof Immunological Societies of Asia-Oceania Congress (FIMSA),Thailand, 2018

 

  1. Chyuan IT,Tsai HF, Hsu PN. TRAIL suppresses joint inflammation andosteoclastogenesis through inhibiting activated T cell responses ininflammatory arthritis [Oral]. Cytokine Congress, Japan, 2017

 

  1. Chyuan IT,Tsai HF, Hsu PN. An apoptosis-independent role of TRAIL insuppressing joint inflammation and inhibiting T cell activation ininflammatory arthritis [Oral]. The 16th TNF Superfamily Meeting.Singapore, 2017

 

  1. Chyuan IT,Tsai HF, Hsu PN. Tumor necrosis factor-related apoptosis-inducingligand (TRAIL) suppresses joint inflammation and bone erosion byinhibiting T cell activation in experimental arthritis [Oral]. The16th International Congress of Immunology. Australia, 2016

 

  1. Chyuan IT,Tsai HF, Hsu PN. TRAIL modulates experimental autoimmuneencephalomyelitis (EAE) by directly inhibiting myelin-specific Tcells activation via TRAIL receptor signaling [Oral]. The Congressof the Chinese Society of Immunology. 2016

 

  1. Chyuan IT,Tsai HF, Hsu PN. Tumor necrosis factor-alpha blockage therapyimpairs hepatitis B viral clearance and enhances T-cell exhaustionin a mouse model [Poster]. The Congress of the Chinese Society ofImmunology. 2015

 

  1. Chyuan IT,Tsai HF, Hsu PN. Tumor necrosis factor-related apoptosis-inducingligand (TRAIL) suppresses joint damage and protects against boneloss by inhibiting T cell activation and inflammation inexperimental arthritis [Oral]. The Congress of the Chinese Societyof Immunology. 2014

 

  1. Chyuan IT,Liao HJ, Hsu PN. Neutrophil infiltration, increased IL-1 productionand SAPHO syndrome-like phenotype in PSTPIP2 deficient mice[Poster]. The 15th International Congress of Immunology. Italy, 2013

 

 

 

4

 

责任编辑: 小渠

上一篇:精准控制 健康护发

下一篇:没有了

最火资讯